Denis Chem Lab Files FY26 Annual Report, Proposes Higher Dividend

Revenue from operations stood at Rs. 181.72 crore in FY 2025-26, up from Rs. 173.29 crore in FY 2024-25. Profit After Tax (PAT) for FY 2025-26 was Rs. 8.41 crore, a rise from Rs. 8.08 crore in the previous year.

Reader Takeaway: Stable growth in revenue and profit, with an increased dividend payout for shareholders.

What just happened

Denis Chem Lab Limited has released its Annual Report for the financial year 2025-26. The report details financial performance, operational strategies, and corporate governance matters. The company also announced its 45th Annual General Meeting (AGM) scheduled for September 25, 2026.

Why this matters

Shareholders gain insight into the company's performance and management's outlook. The proposed dividend increase and leadership continuity signal stability. The report outlines the company's strategy in the transfusion solution and injectable segments.

The backstory

Denis Chem Lab operates in the transfusion solution market, focusing on bottles and plastic bottles. The company has been working on expanding its domestic market share, particularly by acquiring new customers in the premium